Author avatar

Giorgos Aristotelous

About

Giorgos — BSc, MSc. Giorgos is an exercise scientist whose training and professional practice sit at the intersection of human performance, clinical health, and emerging microbiome science. He holds a BSc in Sports Science & Physical Education from Aristotle University (2012) and an MSc in Exercise & Health from Democritus University (2016), where his graduate work explored physiological adaptations to training across the lifespan. Now in his 15th year of practice, Giorgos pairs evidence-based coaching (ACSM-CPT, NSCA, USA Weightlifting) with a research-driven interest in how physical activity, body composition, and musculoskeletal integrity shape—and are shaped by—host–microbiome dynamics.

Recent Posts

2025-07-29 06:13:29

Gut Microbiota in Graves’ Disease: Microbial Signatures and Diagnostic Potential

This study identified distinctive alterations in gut microbiota in Graves’ disease, including reduced diversity and specific taxonomic shifts. Key microbial signatures correlated with thyroid autoimmunity, highlighting potential diagnostic biomarkers and suggesting that microbiome modulation may offer new therapeutic avenues for Graves’ disease.

2025-07-21 20:06:16

Does Physical Exercise Lower Endometriosis Risk? Systematic Review Insights

This systematic review found insufficient evidence to confirm that physical exercise reduces endometriosis risk or symptoms, though some data suggest a potential protective effect. Well-designed controlled trials are needed to clarify the role of exercise in endometriosis prevention and management.

2025-07-07 09:49:26

Resistance (Strength) Training

Resistance (strength) training appears to exert modest but meaningful effects on the human gut microbiome. Unlike aerobic exercise, which often leads to pronounced changes in microbial diversity and taxonomic shifts, short-term resistance training tends to result in minimal changes in overall microbiome composition or alpha-diversity. However, this does not indicate a lack of functional impact. […]

2025-01-01 00:00:00

Correlations between serum cytokines and gut microbiota in patients with Graves’ disease: A case-control study

What was studied?This case–control observational study investigated the associations between peripheral blood cytokine profiles and gut microbiota composition in patients with Graves’ disease (D), the most common autoimmune thyroid disorder. The study aimed to elucidate the interplay between immune dysregulation—specifically changes in cytokines such as interleukin-10 (L-10), transforming growth factor β (GF-β), and interleukin-17A (L-17A)—and […]

2023-01-01 00:00:00

Graves’ Disease Gut Microbiome Signature: Key Genera and Clinical Implications

This prospective study identifies a unique gut microbiome signature in Graves’ disease, characterized by decreased CFA-producing bacteria and increased pro-inflammatory taxa, which partially recovers with antithyroid therapy. Twelve genera robustly distinguish D, offering potential for early diagnosis and microbiome-targeted interventions.

2021-01-01 00:00:00

Gut Microbiota Signatures in Graves’ Disease: Key Associations and Biomarker Potential

This study reveals that Graves’ disease is linked to distinct gut microbiota alterations, particularly increased Ruminococcus and Lactobacillus and decreased Synergistetes and Phascolarctobacterium, which correlate with thyroid autoantibody status and may serve as microbiome-based biomarkers for disease activity and therapeutic response.